Eduardo Bruera, MD

F.T. McGraw Chair in the Treatment of Cancer
Chair, Department of Palliative Care and Rehabilitation Medicine
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas

Dr. Eduardo Bruera received his medical degree from the University of Rosario in Argentina, and his medical oncology training at the University of Salvador, Buenos Aires, Argentina. He holds the F.T. McGraw Chair in the Treatment of Cancer and is Chair of the Department Palliative Rehabilitation and Integrative Medicine at The University of Texas MD Anderson Cancer Center in Houston.

Dr. Bruera holds certification from the American Board of Internal Medicine and American Board of Hospice & Palliative Medicine, and is a fellow of the American College of Physicians and the American Association of Hospice & Palliative Medicine. As a medical oncologist who specializes in palliative medicine, he has conducted and published a large number of clinical trials on the assessment of complex symptoms by patients, families, and health care professionals. He has also conducted a number of randomized, controlled trials and prospective cohort studies on treatment preferences, decision-making, and practical aspects of communication between health care professionals and patients and families. Dr. Bruera has written more than 1000 publications, has edited over 30 books, and has given hundreds of lectures on these topics. His clinical and research interests are related to the assessment and management of physical and psychosocial symptoms in patients with advanced cancer.

Over the last 20 years, Dr. Bruera has trained hundreds of physicians, nurses, and other health care professionals in the different aspects of the clinical delivery of palliative care. He established the first academic fellowship program in palliative care at the University of Alberta in Canada and one of the first academic palliative care fellowships in the United States at The University of Texas MD Anderson Cancer Center.

Last modified: March 14, 2016

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of

©2018 MediCom Worldwide, Inc. All rights reserved